The text of Chairman Upton's remarks in support of H.R. 1938 , the North American-Made Energy Security Act, follows below:
WASHINGTON, DC - The Obama administration's Office of Management and Budget has failed to comply with the House Energy and Commerce Committee's subpoena seeking documents relating to the Department of Energy's issuance of a loan guarantee to Solyndra, Inc. OMB is responsible for reviewing and approving the Credit Subsidy Costs of all DOE loan guarantees.
Michigan Delegation Urges President to Protect U.S. Jobs, Pursue Balanced Approach to Fuel Economy StandardsJuly 22, 2011 | Press Release
WASHINGTON, D.C. - U.S. Senator Carl Levin (D-MI), House Energy and Commerce Chairman Fred Upton (R-MI06), and U.S. Congressman John D. Dingell (D-MI15) were joined by Michigan Delegation colleagues yesterday in sending a letter to President Obama regarding the importance of one national program for vehicle emissions. Below is the text of the letter: Dear Mr. President:
Upton & Shimkus Ask, "Where Are the Findings?" Following NRC's Incomplete Release of Long Overdue Yucca EvaluationJuly 21, 2011 | Press Release
WASHINGTON, DC - Energy and Commerce Committee Chairman Fred Upton (R-MI) and Environment and the Economy Subcommittee Chairman John Shimkus (R-IL) today called on Nuclear Regulatory Commission Chairman Gregory Jaczko to release the full and uncensored safety evaluation for the Yucca Mountain nuclear repository.
House Leaders Welcome Bipartisan Senate Effort to Protect Jobs by Improving and Extending Time to Meet Boiler RulesJuly 21, 2011 | Press Release
WASHINGTON, DC - U.S. House Energy and Commerce Committee Chairman Fred Upton (R-MI) today praised introduction of the Senate's EPA Regulatory Relief Act, a bipartisan Senate proposal that shares many features of a bill introduced last month in the House to protect hundreds of thousands of jobs. Reps. Morgan Griffith (R-VA) and G.K.
WASHINGTON, DC - The House Energy and Commerce Subcommittee on Oversight and Investigations, chaired by Rep. Cliff Stearns (R-FL), today held a hearing on the Food and Drug Administration's medical device regulations and the impact on American patients, innovation, and job creation. Patients and innovators adversely affected by regulatory inconsistencies and inefficiencies at the FDA shared their personal testimonies and Dr.